MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder marked pathologically by the buildup of misfolded β-amyloid (Aβ) peptides, neurofibrillary tangles from hyperphosphorylated tau (p-tau), and progressive synaptic loss [1,2,3].